... 98 percent accurate in scanning the lymph nodes of stage I and stage II ovarian ... technologies have not indicated a definite role in the staging of ovarian cancer, many of the studies involved very small ...
... cervical, or endometrial cancers, suggesting that a particular, distinguishable scent is associated with ovarian cancer. They additionally found that early-stage and low grade ovarian cancers emit the ...
... metastasis are major impediments to the successful treatment of ovarian cancer and until now we had little information ... cell lines to animal models."
The American Cancer Society estimates 15,000 U. ...
... provides clinical benefit to women with relapsed ovarian cancer, according to new results presented at the 33rd ... current standard of treatment for women whose cancer recurs at least 6 months after first ...
... and facing scrutiny.
Does a test that promises to detect ovarian cancer sooner really do so? Could other ...
... none of the control samples tested positive. This suggests that TEM1 is a specific marker for ovarian cancer, which may lead to a potential screening tool.
Li and colleagues have been addressing ...
Researchers have identified TEM1 as a specific genetic marker for the vascular cells associated with tumor growth, a finding that could aid in diagnosis and treatment of ovarian cancer.
Researchers have identified TEM1 as a specific genetic marker for the vascular cells associated with tumour growth, a finding that could aid in diagnosis and treatment of ovarian cancer...
Laurie Gray's mother died of ovarian cancer at the age of 41, more than 30 years ago. For Gray, a Brentwood attorney, a cloud of concern lingered over her own health. ...
Laurie Gray's mother died of ovarian cancer at the age of 41, more than 30 years ago. For Gray, a Brentwood attorney, a cloud of concern lingered over her own health. ...
... Hospital suggest that substantial differences exist between ovarian cancer subtypes which should be reflected in patient ... cancer subtypes separately (high-grade serous, low-grade serous, clear cell, ...
... of 718 patients from 60 institutions with advanced ovarian cancer were enrolled in the study. The women were randomized ... nearly 200,000 women are diagnosed of ovarian cancer each year and every year, ...
... Oncology.
"Although approximately 10% of women with ovarian cancer have a BRCA1 or BRCA2 mutation, the majority ... 55.2%), or personal history of breast cancer (62.1%)
In 2001, the Ontario Ministry ...
... Medicine, David Huntsman and his colleagues from Vancouver General Hospital suggest that substantial differences exist between ovarian cancer subtypes which should be reflected in patient management.
Ovarian cancer cells are "addicted" to a family of proteins produced by the notorious oncogene, MYC, and blocking these Myc proteins halts cell proliferation in the deadliest cancer of the female ...
